ALLO vs AVB · rev $22.0K vs P/E 23, rev $2.91B
Allogene Therapeutics Inc (ALLO) versus AvalonBay Communities Inc (AVB) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported AVB revenue for 2024-12-31 was $2.91B. Net income was $1.08B. Revenue was up 5.3% from 2023-12-31 to 2024-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
ALLO currently screens at market cap $258.1M. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Not investment advice. Open the ALLO and AVB stock pages for the full models.
Not investment advice.